{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:46:27Z","timestamp":1787229987628,"version":"build-2736575974"},"reference-count":19,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0809","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T22:08:30Z","timestamp":1619561310000},"page":"1135-1141","source":"Crossref","is-referenced-by-count":6,"title":["A mosaic mutation of phosphate-regulating gene with homologies to endopeptidases on the X chromosome (&lt;i&gt;PHEX&lt;\/i&gt;) in X-linked hypophosphatemic rickets with mild bone phenotypes"],"prefix":"10.1507","volume":"68","author":[{"given":"Shoko","family":"Asano","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Sako","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Funasaki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumie","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo","family":"Niida","sequence":"additional","affiliation":[{"name":"Division of Genomic Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa 920-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Ishikawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, et al. (2015) Nationwide survey of fibroblast growth factor 23 (FGF23)\u2014related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J 62: 811\u2013816.","DOI":"10.1507\/endocrj.EJ15-0275"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, et al. (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19: 429\u2013435.","DOI":"10.1359\/JBMR.0301264"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Beck L, Soumounou Y, Martel J, Krishnamurthy G, Gauthier C, et al. (1997) Pex\/PEX tissue distribution and evidence for a deletion in the 3&apos; region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 99: 1200\u20131209.","DOI":"10.1172\/JCI119276"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Lahiri DK, Schnabel B (1993) DNA isolation by a rapid method from human blood samples: effects of MgCl<sub>2<\/sub>, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 31: 321\u2013328.","DOI":"10.1007\/BF00553174"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Niida Y, Kuroda M, Mitani Y, Okamura A, Yokoi A (2012) Applying and testing the conveniently optimized enzyme mismatch cleavage method to clinical DNA diagnosis. Mol Genet Metab 107: 580\u2013585.","DOI":"10.1016\/j.ymgme.2012.09.008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Tsuji T, Niida Y (2008) Development of a simple and highly sensitive mutation screening system by enzyme mismatch cleavage with optimized conditions for standard laboratories. Electrophoresis 29: 1473\u20131483.","DOI":"10.1002\/elps.200700729"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, et al. (2001) Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 86: 3889\u20133899.","DOI":"10.1210\/jcem.86.8.7761"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Gaucher C, Walrant-Debray O, Nguyen TM, Esterle L, Garab\u00e9dian M, et al. (2009) PHEX analysis in 118 pedigrees revels new genetic clues in hypophosphetamic rickets. Hum Genet 125: 401\u2013411.","DOI":"10.1007\/s00439-009-0631-z"},{"key":"9","unstructured":"9 Basu D, Pettifor JM, Kromberg J (2004) X-linked hypophosphatemia in South Africa. S Afr Med J 94: 460\u2013464."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Song HR, Park JW, Cho DY, Yang JH, Yoon HR, et al. (2007) PHEX gene mutations and genotype-phenotype analysis of Korean patients with hypophosphatemic rickets. J Korean Med Sci 22: 981\u2013986.","DOI":"10.3346\/jkms.2007.22.6.981"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Weng C, Chen J, Sun L, Zhou ZW, Feng X, et al. (2016) A <i>de novo<\/i> mosaic mutation of PHEX in a boy with hypophosphatemic ricket. J Human Genet 61: 223\u2013227.","DOI":"10.1038\/jhg.2015.133"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Goji K, Ozaki K, Sadewa AH, Nishio H, Matsuo M (2006) Somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait. J Clin Endocrinol Metab 91: 365\u2013370.","DOI":"10.1210\/jc.2005-1776"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Yang M, Kim J, Yong A, Jang J, Jeon TY, et al. (2018) A novel <i>de novo<\/i> mosaic mutation in PHEX in a Korean patient with hypophosphatemic rickets. Ann Pediatr Endocrinol Metab 23: 229\u2013234.","DOI":"10.6065\/apem.2018.23.4.229"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Wolf M (2012) Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 87: 737\u2013747.","DOI":"10.1038\/ki.2012.176"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15 Delacey S, Liu Z, Broyles A, El-Azab SA, Guandique CF, et al. (2019) Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients. Bone 127: 386\u2013392.","DOI":"10.1016\/j.bone.2019.06.025"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res 26: 1381\u20131388.","DOI":"10.1002\/jbmr.340"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Makitie O, Kooh SW, Sochett E (2003) Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Clin Endocrinol (Oxf) 58: 163\u2013168.","DOI":"10.1046\/j.1365-2265.2003.01685.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Carpenter TO, Whyte MP, Imel EA, Boot AM, H\u00f6gler W, et al. (2018) Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med 378: 1987\u20131998.","DOI":"10.1056\/NEJMoa1714641"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 An Insogna KL, Briot K, Imel EA, Kamenick\u00fd P, Ruppe MD, et al. (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, anti\u2014FGF23 antibody, in adults with X-linked hypophosphatemia: Week 24 primary analysis. J Bone Miner Res 33: 1383\u20131393.","DOI":"10.1002\/jbmr.3475"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/9\/68_EJ20-0809\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T03:30:55Z","timestamp":1633145455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/9\/68_EJ20-0809\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0809","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"EJ20-0809"}}